ResMed Backtesting

RMD -- USA Stock  

USD 107.03  0.90  0.83%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of ResMed and determine expected loss or profit from investing in ResMed over given investment horizon. Additionally take a look at ResMed Hype Analysis, ResMed Correlation, ResMed Valuation, ResMed Volatility as well as analyze ResMed Alpha and Beta and ResMed Performance.
 Time Horizon     30 Days    Login   to change
SymbolX
Backtest

ResMed 'What if' Analysis

May 25, 2018
0.00
No Change 0.00  0.0%
In 31 days
June 24, 2018
0.00
If you would invest  0.00  in ResMed on May 25, 2018 and sell it all today you would earn a total of 0.00 from holding ResMed or generate 0.0% return on investment in ResMed over 30 days. ResMed is related to or competes with DexCom, Boston Scientific, Cooper Companies, Quest Diagnostics, DENTSPLY SIRONA, Stryker, and TELEFLEX INC. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that ...

ResMed Upside/Downside Indicators

Downside Deviation0.8649
Information Ratio0.2929
Maximum Drawdown2.42
Value At Risk0.90
Potential Upside1.45
  

ResMed Market Premium Indicators

Risk Adjusted Performance0.01
Sortino Ratio0.2637

ResMed Backtested Returns

Macroaxis considers ResMed not too risky given 1 month investment horizon. ResMed maintains Sharpe Ratio (i.e. Efficiency) of 0.2836 which implies ResMed had 0.2836% of return per unit of risk over the last 1 month. Our philosophy towards forecasting volatility of a stock is to use all available market data together with company specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for ResMed which you can use to evaluate future volatility of the company. Please employ ResMed Coefficient Of Variation of 341.44, Semi Deviation of 0.5772 and Risk Adjusted Performance of 0.01 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100 ResMed holds performance score of 18. The organization holds Beta of 0.0 which implies the returns on MARKET and ResMed are completely uncorrelated. Although it is extremely important to respect ResMed current trending patterns, it is better to be realistic regarding the information on equity existing price patterns. The philosophy towards forecasting future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By analyzing ResMed technical indicators you can presently evaluate if the expected return of 0.2314% will be sustainable into the future. Please employ ResMed Information Ratio, Value At Risk as well as the relationship between Value At Risk and Expected Short fall to make a quick decision on weather ResMed historical price patterns will revert.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation 0.25 

Poor predictability

ResMed has poor predictability. Overlapping area represents the amount of predictability between ResMed time series from May 25, 2018 to June 9, 2018 and June 9, 2018 to June 24, 2018. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ResMed price movement. The serial correlation of 0.25 indicates that over 25.0% of current ResMed price fluctuation can be explain by its past prices.
Correlation Coefficient 0.25
Spearman Rank Test 0.45
Price Variance 0.31
Lagged Price Variance 3.4

ResMed lagged returns against current returns

 Current and Lagged Values 
      Timeline 

ResMed regressed lagged prices vs. current prices

 Current vs Lagged Prices 
      Timeline 

ResMed Lagged Returns

 Regressed Prices 
      Timeline 

Current Sentiment - RMD

ResMed Investor Sentiment
Greater number of Macroaxis users are at this time bullish on ResMed. What is your perspective on investing in ResMed? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Trending Equities

Currently Active Assets on Macroaxis
OZL   
Purchased over 100 shares of
over a week ago
Traded for 10.44
FBU   
Purchased over 300 shares of
over a week ago
Traded for 6.24
JBH   
Purchased over 70 shares of
over a week ago
Traded for 23.42
GNC   
Purchased over 200 shares of
over a week ago
Traded for 8.1
SBM   
Purchased over 400 shares of
over a week ago
Traded for 4.74
Additionally take a look at ResMed Hype Analysis, ResMed Correlation, ResMed Valuation, ResMed Volatility as well as analyze ResMed Alpha and Beta and ResMed Performance. Please also try Bollinger Bands module to use bollinger bands indicator to analyze target price for a given investing horizon.